PhotoniCare
Private Company
Total funding raised: $5.5M
Overview
PhotoniCare is a commercial-stage medical device company revolutionizing the diagnosis of middle ear infections (otitis media) with its handheld OtoSight Middle Ear Scope. The device utilizes a miniaturized form of Optical Coherence Tomography (OCT) to provide objective, high-resolution 3D imaging of the middle ear behind the eardrum, even in the presence of earwax. Peer-reviewed clinical data demonstrates the technology's high accuracy in detecting middle ear effusion and its potential to reduce antibiotic prescriptions by 50%. With its patented imaging platform, the company is exploring expansion into other diagnostic applications in dermatology, ophthalmology, and dentistry.
Technology Platform
Miniaturized handheld Optical Coherence Tomography (OCT) imaging platform that uses near-infrared light to provide high-resolution, cross-sectional 3D views inside living tissue.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
In otology, OtoSight faces competition from traditional pneumatic otoscopes and tympanometry, but is first-in-class for direct middle ear imaging. For pipeline applications, competition is intense: in ophthalmology, against large desktop OCT systems (Zeiss, Heidelberg) and emerging handheld devices; in dermatology, against dermoscopes and other imaging modalities; and in dentistry, against intraoral cameras and X-rays. PhotoniCare's differentiation is its specific miniaturization for primary care use.